Compare GEF & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | GEF | INDV |
|---|---|---|
| Founded | 1877 | N/A |
| Country | United States | United States |
| Employees | 12000 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | 2014 |
| Metric | GEF | INDV |
|---|---|---|
| Price | $70.26 | $30.57 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $73.33 | N/A |
| AVG Volume (30 Days) | 190.0K | ★ 3.0M |
| Earning Date | 04-28-2026 | 06-08-2026 |
| Dividend Yield | ★ 3.19% | N/A |
| EPS Growth | N/A | ★ 8100.00 |
| EPS | N/A | ★ 1.64 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $0.73 | N/A |
| Revenue Next Year | $1.32 | N/A |
| P/E Ratio | ★ $4.09 | $19.68 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $50.24 | $8.69 |
| 52 Week High | $77.14 | $38.00 |
| Indicator | GEF | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 60.87 | 47.42 |
| Support Level | $69.34 | $29.71 |
| Resistance Level | $77.14 | $35.75 |
| Average True Range (ATR) | 1.46 | 1.18 |
| MACD | 0.72 | 0.31 |
| Stochastic Oscillator | 89.54 | 57.87 |
Greif Inc is a producer of industrial packaging products and services with manufacturing facilities located in many countries. It offers a comprehensive line of rigid industrial packaging products, such as steel, fiber, and plastic drums, rigid intermediate bulk containers, closure systems for industrial packaging products, transit protection products, water bottles and remanufactured and reconditioned industrial containers, and services, such as container life cycle management, blending, filling, logistics, warehousing, and other packaging services. The company operates in three reportable business segments including Global Industrial Packaging, Paper Packaging and Services, and Land Management. It operates in USA, Europe, Middle East, Africa and Asia and Other Americas.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).